The UK government allocates GBP 5 million for the Fleming Centre, a partnership between Imperial College London and Imperial College Healthcare NHS Trust for cutting-edge research, public engagement and work with policymakers towards fighting antimicrobial resistance (AMR).
Professor the Lord Darzi of Denham, who serves as the centre's chairman, says, “I am delighted the Chancellor has recognised the importance of tackling antimicrobial resistance and investing in the Fleming Centre. This £5 million funding will help to develop our plans and unlock further funding and support to address this global challenge.”
مقتطفات
The Chancellor of the Exchequer has announced that £5million will be made available to the Fleming Centre – a partnership between Imperial College London and Imperial College Healthcare NHS Trust.
The announcement was made in the 2023 Autumn Statement today (Wednesday 22 November), as part of a suite of funding aimed at bolstering the UK’s life sciences sector.
Due to open in 2028, the centre will be based at the St Mary’s Hospital site in Paddington, London, where the first antibiotic was discovered by Sir Alexander Fleming in 1928.